Study Title and Description
Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4.
Key Questions Addressed
|7||Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?|
|8||Key Question 8. What are the harms of currently recommended antiviral treatments?|
Primary Publication Information
|Title||Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4.|
|Author||Abdel Ghaffar TY., El Naghi S., Abdel Gawad M., Helmy S., Abdel Ghaffar A., Yousef M., Moafy M.|
|Country||Yassin Abdel Ghaffar Charity Center for Liver Disease and Research, Cairo, Egypt.|
Pubmed ID: 30380158
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-9
Results & Comparisons
No Results found.